A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial (Q34662809)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial |
scientific article |
Statements
1 reference
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial (English)
1 reference
Michael P Boyle
1 reference
Scott C Bell
1 reference
Michael W Konstan
1 reference
Susanna A McColley
1 reference
Steven M Rowe
1 reference
Ernst Rietschel
1 reference
Xiaohong Huang
1 reference
David Waltz
1 reference
Naimish R Patel
1 reference
David Rodman
1 reference
VX09-809-102 study group
1 reference
1 reference
Identifiers
1 reference